Lower-Dose Radioiodine Effective Against Thyr... ( By Carina Storrs HealthDay Repor...)

Lower-Dose Radioiodine Effective Against Thyroid Cancer

Date:5/2/2012

By Carina Storrs
HealthDay Reporter

WEDNESDAY, May 2 (HealthDay News) -- People with thyroid cancer are often given a radioactive iodine treatment to wipe out stray cancer cells, a treatment that comes with its own health risks.

Now, two new studies find that a safer, lower dose of radioactive iodine is just as effective as the higher dose at getting rid of any such cells that remain after surgery.

The research also found that patients were just as likely to have their thyroid shrunk away if they took a drug called Thyrogen (thyrotropin) as if they underwent thyroid hormone withdrawal -- which leads to fatigue, pain and weight gain -- before embarking on the radioiodine treatment.

The two studies, published in the May 3 issue of the New England Journal of Medicine, compared low- and high-dose radioactive iodine in a total of more than 1,000 patients. The participants, from Britain and France, also received either Thyrogen or thyroid hormone withdrawal as part of the therapy.

In either study, the researchers found that patients who received the low-dose (30 millicuries) of radioactive iodine in combination with Thyrogen were just as apt to have their remaining thyroid cells mopped up -- with fewer side effects -- than patients who received higher-dose (100 millicuries ) radioiodine along with either Thyrogen or hormone withdrawal.

However, the researchers say they plan on monitoring the patients for several years to see if rates of cancer recurrence are similar in the different groups.

"We try to give the lowest possible effective radiation dose so that we cure the current cancer, but we do not increase the risk of producing a second cancer resulting from the radiation itself," explained Dr. Ujjal Mallick, an oncologist at the Northern Centre for Cancer Care in Newcastle upon Tyne, in England, and lead author of the UK study.

Radioactive iodine has been associated with increased ris
'/>"/>

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. Lower-dose heparin use during coronary procedure does not appear to reduce risk of major bleeding
2. Pig stomach mucins are effective as anti-viral agents for consumer products
3. HIV Prevention Pill Cost-Effective for High-Risk Men: Study
4. Early clinical data show galeterone safe, effective against prostate cancer
5. Coaching Boys into Men an effective tool for stopping teen dating violence
6. How cost effective are US cancer prevention services?
7. Study finds expensive procedure no more effective than medical therapy to prevent strokes
8. Broader screening for hepatitis C would be cost effective, study suggests
9. More effective treatments urgently needed for adolescent depression
10. Mayo Clinic review: Blood pressure drug effective for treating PTSD-related nightmares
11. How chemotherapy becomes more effective

Post Your Comments:

Related Image:

Lower-Dose Radioiodine Effective Against Thyroid Cancer

(Date:6/19/2013)... Mesothelioma Victims Center says, "According to the ... citizens, who will be diagnosed with a rare form ... will be US Navy Veterans. We can assure a ... of cancer, or their family members that we will ... mesothelioma compensation settlement attorneys, who actually do have a ...

(Date:6/19/2013)... Faith4Kidz is starting a new fundraising effrt ... would like help showing support for kids to learn how ... positive. Check out the website, http://www.gracenfaith.com to see ... red, white and blue stars as a symbol of our ... as well as the stars we should encourage our children ...

(Date:6/18/2013)... Exposed Skin Care has finally been released after much ... ages finally achieve the clear, beautiful skin they have always ... clearing system combines the power of science and nature to ... , After a quick review of Exposed ... the most effective available on the market to cure acne ...

(Date:6/18/2013)... South Africa (PRWEB) June 19, 2013 Looking ... disillusionment and monotony of everyday life? , IWALKAWAKE is ... awakening process. Written by Adam Botha, it focuses on harnessing ... , The book lays out a nine-step guide to ... a process that a person must go through to reach ...

(Date:6/18/2013)... York (PRWEB) June 19, 2013 The ... understanding and unprecedented access to the drug delivery partnering ... healthcare companies. , The report provides a detailed ... drug delivery partnering deals. The majority of deals are ... right or an option right to license the license ...

Breaking Medicine News(10 mins):Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation 2 Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation 3 Health News:Faith4Kidz Introduces Patriotic Hats to Benefit the "Grace in Faith Equals Peace" Mission 2 Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 2 Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 3 Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 2 Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 3 Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 4

[0] Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation [0] Faith4Kidz Introduces Patriotic Hats to Benefit the "Grace in Faith Equals Peace" Mission [0] Exposed Skin Care Review Released by ExposedSkinCareReview.org [0] Learn How To Stop Sleepwalking Through Life in New Book 'IWALKAWAKE'[0] New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz

... The Institute for Health Freedom (IHF) is warning the ... government to plan for each American to use "an" ... or patient-consent provisions."Congress needs to add opt-out and patient-consent ... IHF president. "The bottom line is that if YOU ...

... Full Value,Committee announced today that it has filed ... materials and is commencing,distribution of those soliciting materials ... ) ("LCAV") to solicit consents to replace the ... highly qualified nominees. The Full,Value Committee,s director ...

... 9 Team Health Inc.,s,parent company, Team Finance LLC ... fiscal year and the fourth quarter ended,December 31, 2008. ... for uncollectibles ("revenue less provision"),for the fiscal year ended ... billion in the prior year. Same contract revenue less ...

... Powerful opioid drugs can pose risks even for patients, ... The U.S. Food and Drug Administration announced plans Monday ... painkillers by requiring manufacturers of certain opioid drugs to ... with the medications. , The FDA said it has ...

... genes can be used to reliably identify the four ... at Washington University School of Medicine in St. Louis ... potentially predict the most effective therapy for each breast ... all patients., "Unlike a widely used genomic test that ...

... adolescent use of prescription pain relievers has dropped, report ... of prescription painkillers among young adults increased from 4.1 ... government report released Monday shows. , However, the researchers ... (SAMHSA) also found that non-medical use of painkillers by ...

Economic Stimulus Bill Mandates Electronic Health Records for Every American by 2014 - With No Opt-out Provision The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders Team Finance LLC Announces Fiscal 2008 Financial Results FDA Seeks Better Regulation of Painkillers New genomic test can personalize breast cancer treatment Painkiller Abuse Increases Among Young Adults

(Date:6/18/2013)... , June 18, 2013 Decision Resources, ... firms for pharmaceutical and healthcare issues, announces that ... of the Middle East ... Tracker analyzes the challenges and opportunities to gaining ... international regions comprising 24 countries. The countries covered ...

(Date:6/18/2013)... , June 18, 2013 New-generation ... being highly portable and lightweight. Simultaneously, circuitry is ... the processing speed to which it performs at. ... medical electronics and military equipment, such as cameras ... Omnetics, micro-circular and nano-circular connectors include custom cable ...

(Date:6/18/2013)... And EMERYVILLE, Calif. , June ... final results today from a Phase 2/3 clinical ... demonstrating a statistically significant improvement in levodopa-induced dyskinesia ... week 8 versus placebo in the Unified Dyskinesia ... formulation of amantadine intended for once-nightly administration that ...

Breaking Medicine Technology:Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 2 Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 3 Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2 Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 2 Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 3 Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 4 Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 5 Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 6

[0] Decision Resources' Market Access Tracker Now Covers the Middle East and Africa [0] Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility [0] Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease

... Therapeutics, Inc. (NASDAQ: ECTE ), a company ... wireless, transdermal continuous glucose monitoring system and its Prelude® ... Patrick T. Mooney, M.D., Chairman & CEO of Echo ... Conference. Dr. Mooney will make a presentation ...

... Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) today ... operating officer, is scheduled to present a company overview ... York City on Wednesday, December 14th at 1:00 p.m. ... ) To access the live audio webcast ...

Cached Medicine Technology:

Echo Therapeutics to Present at the Oppenheimer Healthcare Conference Rigel to Present at Oppenheimer Annual Healthcare Conference

... result of DEKA s new technology ... different methods capable of restoring a ... treatment is designed to dramatically reduce ... combined action of a localized cooling ...

... its great versatility in epilation and ... the compactness and easy-transportability of the ... protocols developed for Smartepil II plus, ... indicated for hair removal of tricky ...

... new and efficient method applied to dermatological ... ongoing research and development with hundreds of ... light source, but rather a platform for ... horizons in pulsed-light-based technology, the most valid ...

Auto Refkeratomoeter...

Medicine Products:

Triactive SmartEpil LS Photosilk Plus Refkeratometer KW-2000